Maggot Debridement Market Overview
Maggot Debridement Market size is estimated to be $9.63 million in 2019, growing at a CAGR of 8.7% during the forecast period 2020-2025. Maggot Debridement is a form of therapeutic wound treatment in which sterile or disinfected larvae of certain blowfly species are used to remove non-vitalized tissue, pus, slough and metabolic waste on the wound and promote healing. Maggot Debridement is also known as maggot therapy, bio debridement, larval therapy, biosurgery, biotherapy and bio surgical debridement. Moreover, maggot debridement is a safe, effective and controlled method of healing chronic wounds by debridement and disinfection. Growing geriatric population, changing lifestyle, wrong eating habits, chronic illness leading to diabetes are some of the key factors driving the maggot debridement market in the upcoming years. Moreover, according to World Health Organization in 2016 an estimated 1.6million deaths were directly caused by diabetes and between 2000 and 2016, there was a 5% increase in premature mortality from diabetes. Furthermore, increased cases of diabetes can lead to diabetic foot ulcers, venous leg ulcers and pressure ulcers which would eventually driving the maggot debridement market during the forecast period 2020-2025.
Maggot Debridement Market Report Coverage
The report: “Maggot Debridement Market Forecast (2020-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the Maggot Debridement Market.
By Administration- Loose Larva and Biobags.
By Application- Chronic Wounds and Acute Wounds.
By End-User-Hospitals, Clinics and others.
By Geography-North America, Europe, Asia Pacific and Rest of the World.
- Chronic wounds segment held the largest market share in the year 2019 owing to the rising number of people suffering from diabetes foot ulcers, pressure ulcers and venous leg ulcers.
- Hospitals accounted for the largest market share in 2019 owing to the increasing number of people suffering from various chronic wounds treated there.
- North America dominated the Maggot Debridement Market owing to the rising geriatric population suffering from diabetes, increasing health concerns and a better healthcare structure is a major factor propelling its market growth.
- Large Number of People Suffering from acute wounds including surgical wounds and burn wounds is a major driving the Maggot Debridement Market during the forecast period 2020-2025.
Maggot Debridement Market Segment Analysis - By Application
By Application the Maggot Debridement is segmented into Chronic Wounds and Acute Wounds. Chronic wounds segment held the largest market share in the year 2019 owing to the rising number of people suffering from diabetes foot ulcers, pressure ulcers and venous leg ulcers. Diabetes foot ulcers is an open sore or wound that effects approximately 15 percent of patients with diabetes and is commonly located at the bottom of the foot. In addition, people suffering from foot ulcers are generally hospitalized owing to the infection and other ulcer-related complication. Furthermore, according to NCBI the annual incidence of diabetic foot ulcer worldwide is between 9.1 to 26.1million. Around 15% to 25% patients with diabetes mellitus would develop a diabetic foot ulcer in their lifetime. Also, acute wounds segment is projected to witness growth at fastest CAGR of 8.3% in forecast period 2020-2025 owing to the increase in the prevalence of people affected by various burns and wounds is a vital factor up surging its market growth. Moreover, according to World Health Organization in South Africa an estimated $26 million is spent annually for care of burns from kerosene cookstove incidents.
Maggot Debridement Market Segment Analysis - By End-User
Hospitals accounted for the largest market share in 2019 owing to the increasing number of people suffering from various chronic wounds treated there. Moreover, according to the U.S. Department of Health & Human Services each year more than 2.5 million people in the United States develop pressure ulcers. The skin lesions brings pain, associated risk for serious infection and increased care utilization. Besides, this the presence of toolkit to assist hospital staff in implementing effective pressure ulcer prevention practices is another vital factor fueling its market growth. Furthermore, the growth of this segment is majorly owing to the increasing number of acute wounds including surgical wounds and burn wounds.
Maggot Debridement Market Segment Analysis - By Geography
North America dominated the Maggot Debridement Market with a region share 38.10% in 2019 followed by APAC and Europe. Rising geriatric population along with the increase in the number of people suffering from diabetes, increasing health concerns along with the growing demand of advanced treatment and a better healthcare structure is a major factor propelling its market growth. Furthermore, the presence of large number of key players in the region is highly supporting its market growth. Moreover, according to the Centers for Disease Control and Prevention about 34.2 million Americans just over 1 in 10 have diabetes and 88 million in American adults approximately 1 in 3 have prediabetes.
Maggot Debridement Market Drivers
Large Number of People Suffering from Acute Wounds
Large Number of People Suffering from acute wounds including surgical wounds and burn wounds is a major driving the Maggot Debridement Market during the forecast period 2020-2025. Moreover, the growing number of patients suffering from burn wounds and their will to adapt to different types of treatment is propelling the demand of Maggot Debridement Market during the forecast period 2020-2025. Furthermore, according to the Centers for Disease Control, 1.1million people suffer from burn injuries that require medical attention every year in the U.S. approximately 50,000 of these burn injuries require hospitalization and 20,000 suffer from major burns covering 25% of their body surface. Roughly 4,500 burn victims die annually as a result of their injuries and as many as 10,000 people in the U.S. die each year as a result of burn-related infections.
Large Pool of People Suffering From Venous Leg Ulcer in the United States
Large pool of people suffering from venous leg cancer in the U.S. is a vital factor driving Maggot Debridement Market during the forecast period 2020-2025. A venous leg cancer is a sore on the leg that’s very slow to heal, usually owing to the weak blood circulation of the limb. Moreover, according to the National Institute of Health in the U.S. it is estimated that venous leg cancer cause the loss of 2 million working days per year. VLU accounts for 70%-90% of ulcers found on the lower leg and the prevalence of venous ulcers in the U.S. is approximately 600,000 annually.
Maggot Debridement Market Challenges
Side-Effects of Maggot Debridement
Side-effects of maggot debridement serves as a major setback for the growth of the Maggot Debridement Market during the forecast period 2020-2025. The maggot debridement treatment have a limited effectiveness, intense pain and mechanical damage to lower body tissue. Also, high cost of treatment is another factor hampering its market growth.
Maggot Debridement Market Industry Outlook
Product Launches, Merger & Acquistion, joint ventures, and R&D activities are key strategies adopted by the players in Maggot Debridement Market. Maggot Debridement Market top 10 companies are BioMonde, Monarch Labs, Mega Pharma Ltd, Smith, Nephew, BSN, Ethicon Inc., Paul Hartmann AG, 3M Company and Baxter International Inc.,
Maggot Debridement Market Developments:
- April 2016: UP and Inqaba Biotech collaborated for maggot therapy in South Africa.
For more Lifesciences and Healthcare related reports, please click here
1. Maggot Debridement Market Overview
1.1 Definitions and Scope
2. Maggot Debridement Market - Executive Summary
2.1 Market Revenue and Key Trends by Company
2.2 Key trends by Administration
2.3 Key trends by Application
2.4 Key trends by Geography
3. Maggot Debridement Market –Comparative Analysis
3.1 Product Benchmarking - Key companies
3.2 Financials Analysis - Key Companies
3.3 Market Share Analysis- Key Companies
3.4 Patent Analysis
3.5 Pricing Analysis
4. Maggot Debridement Market- Startup companies Scenario Premium Premium
4.1 Key Startup Company Analysis by
4.1.3 Application Analysis
4.1.4 Venture Capital and Funding Scenario
5. Maggot Debridement Market – Industry Market Entry Scenario Premium Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case Studies of Successful Ventures
6. Maggot Debridement Market Forces
6.1 Market Drivers
6.2 Market Constraints
6.3 Porters Five Force Model
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7. Maggot Debridement Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Market life cycle
8. Maggot Debridement Market – By Administration(Market Size –$Million/$Billion)
8.1 Loose Larva
9. Maggot Debridement Market – By Application(Market Size –$Million/$Billion)
9.1 Chronic Wounds
9.1.1 Diabetes Foot Ulcers
9.1.2 Pressure Ulcers
9.1.3 Venous Leg Ulcers
9.2 Acute Wounds
9.2.1 Surgical Wounds
9.2.2 Burn Wounds
10. Maggot Debridement Market – By End-User(Market Size –$Million/$Billion)
11. Maggot Debridement Market - By Geography (Market Size -$Million/$Billion)
11.1 North America
11.2.6 Rest of Europe
11.3.3 South Korea
11.3.5 Australia & New Zealand
11.3.6 Rest of APAC
11.4 Rest of the World
11.4.1 Middle East
11.4.3 South America
12. Maggot Debridement Market - Entropy
13. Maggot Debridement Market – Industry/Segment Competition Landscape Premium
13.1 Market Share Analysis
13.1.1 Global Market Share – Key Companies
13.1.2 Market Share by Region – Key companies
13.1.3 Market Share by Country- Key companies
13.1.4 Best Practices for Companies
14. Maggot Debridement Market – Key Company List by Country Premium Premium
15. Maggot Debridement Market Company Analysis
15.1 Company Revenue, Products, M&A, Developments
15.3 Monarch Labs
15.4 Mega Pharma Ltd
15.8 Ethicon Inc.,
15.9 Paul Hartmann AG
15.10 3M Company
15.11 Baxter International Inc.,
*Financials for private companies would be provided on a best efforts basis”.